MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia
Clinical trial NCT00274248 · COMPLETED
Trial details
- NCT number
- NCT00274248
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Primary completion
- 2007-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.